6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Altamira Therapeutics Ltd.
Filed: January 27, 2023
Period of Report: January 27, 2023
Accession Number: 0001213900-23-005483

View Document ↗ View on SEC.gov ↗